Highlight
The TAP-IT trial evaluated the role of routine thoracentesis added to standard medical therapy in acute heart failure patients with moderate pleural effusion. No significant benefit was demonstrated in days alive out of hospital, mortality, or hospital stay length. Procedural complications were rare, supporting safety of thoracentesis but questioning its routine use.
